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Dear Sirs,
The estimated relative cerebral blood volume (rCBV) is a
semiquantitative parameter that correlates with tissue vas-
cularisation. High-grade gliomas are characterised by an
increased macrovasculature and microvasculature, and
therefore associated with an increased rCBV [1]. In neuro-
oncology, high rCBV is used to distinguish tumoral from
non-tumoral increase in lesion size, e.g, pseudoprogression
and radiation necrosis from real tumour progression.
However, in high-grade glioma an increase in rCBV
without tumour progression can also be observed in (non-
convulsive) status epilepticus, as we will describe below.
A 45-year-old woman was admitted to our hospital
because of a complete paresis of the right arm and motor
speech impairment. Thirteen years before she had been
treated for an anaplastic oligodendroglioma of the left
temporal lobe with surgery followed by radiotherapy
(59.4 Gy) and chemotherapy (6 cycles of procarbazine,
CCNU, vincristin). Every 6 months a magnetic resonance
imaging (MRI) scan of the brain was performed showing a
post-surgery cyst and local subtle enhancement, which
remained stable over this period (Fig. 1a). Dynamic sus-
ceptibility contrast (DSC) perfusion-weighted MR imaging
[T2*w gradient echo echo-planar imaging with repetition
time of 2,000 ms; 60 phases; contrast bolus injection after
10 phases at 5 ml/s of 12 ml of Gadovist 1.0 (Bayer
Schering Pharma) followed by 20 ml 0.9% NaCl; preload
bolus of 3 ml of Gadovist 1.0 (Bayer Schering Pharma)
5 min prior to DSC perfusion imaging] performed
5 months before admission showed rCBV ratios of 1.09
(insular L) and 1.18 (occipital L) (Fig. 1d). One week
before admission, she had woken up with a headache, a
paresis of her right arm and an increased speech impair-
ment. In the following days her headache subsided and her
paresis was fluctuating. On admission she showed a mixed
aphasia, right hemianopia and a complete paresis of her
right arm. An electroencephalogram (EEG) showed clear
epileptic discharges located left centroparietal without
clinical corresponding symptoms. A MRI scan of the brain
showed cortical swelling with extensive cortical enhance-
ment of the left temporal lobe (Fig. 1b), and perfusion-
weighted imaging showed rCBV ratios of 2.24 (insular L)
and 1.64 (occipital L) (Fig. 1e), suggesting tumour pro-
gression. The patient was treated with anti-epileptic drugs
followed by an improvement of clinical symptoms. A
repeat MRI made 2 months later showed a decrease of
enhancement (Fig. 1c) and of rCBV ratios (1.07 insular L
and 0.78 occipital L) (Fig. 1f) to near-baseline values,
indicating the increase in contrast enhancement and rCBV
was not due to tumour progression.
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Radiological seizure-associated abnormalities in epi-
lepsy have been described before. The changes that can be
seen on MR imaging are mainly characterised by focal
cortical swelling and diffusion restriction due to cytogenic
and vasogenic oedema [2], but leptomeningeal and/or
cortical enhancement can also be seen [3], suggesting a
disruption of the blood brain barrier. Recently, Rheims
et al. [4] described ten patients with extensive transient
cortical and leptomeningeal contrast-enhancement in the
context of seizures in brain tumour patients previously
treated with radiotherapy. They argue that the marked and
extensive enhancement they observed (labelled peri-ictal
pseudoprogression), might be related to a postradiation
vasculopathy. Although they also mention a moderate
increase of rCBV in two patients, no data on this are
provided, and follow-up rCBV is not mentioned. It is
therefore unsure whether their findings were also transient.
Another late reversible complication seen in brain
tumour patients after radiation therapy is the so-called
SMART syndrome (stroke-like migraine attacks after
radiation therapy) [5]. To what extent our case is part of the
SMART syndrome and to what extent the SMART syn-
drome is due to seizures are at present unclear.
Our case shows that, despite the known association
between increased rCBV and tumour progression, rCBV
increase should be interpreted with caution, and peri-ictal
pseudoprogression should be considered as well.
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Fig. 1 T1-weighted MRI with gadolinium a 5 months prior to admission, b during admission, c 2 months after admission, d–f DSC perfusion-
weighted MRI d 5 months prior to admission, e during admission, and f 2 months after admission
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